Julie Rubinstein, President at Adaptive Biotechnologies Corp (ADPT), sold 58,751 shares at $56.13 ($3.3M) on 2021-02-25, disclosed to the SEC on 2021-02-26.
Open-market sale of $3.3M ADPT by President. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $56.45 | 4,234 | $239K | 7.1% |
| 2 | $56.45 | 4,234 | $239K | 7.1% |
| 3 | $57.12 | 4,134 | $236K | 7.1% |
| 4 | $57.12 | 4,134 | $236K | 7.1% |
| 5 | $58.74 | 3,374 | $198K | 5.9% |
| 6 | $58.74 | 3,374 |
| $198K |
| 5.9% |
| 7 | $59.33 | 3,258 | $193K | 5.8% |
| 8 | $59.33 | 3,258 | $193K | 5.8% |
| 9 | $56.13 | 14,076 | $790K | 23.6% |
| 10 | $56.13 | 14,076 | $790K | 23.6% |
| 11 | $57.33 | 599 | $34K | 1.0% |
| Total | $56.98 avg | 58,751 | $3.3M | 100% |
| Filing → |
| ADPT | SELL | 2026-10-05 | $1.0M | — | Filing → |
| ADPT | SELL | 2026-04-29 | $271K | — | Filing → |
| ADPT | SELL | 2026-04-24 | $798K | — | Filing → |